Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Health services and systems news

Show

From To
Top gay sexual health clinic forced to turn away four out of five people a day

Around 1,500 people are trying to get just 300 appointments at the most popular sexual health clinic for gay and bi men in the UK, after other clinics closed. Now experts are warning the cuts could lead to sexual infections rising in the UK capital.

Published
30 October 2017
From
Gay Star News
Why AIDS Film “BPM” Has So Many Love Scenes—and So Much Dancing

The film’s director and stars also discuss how ACT UP Paris differed from U.S. activism and what young viewers find exciting about “BPM.”

Published
30 October 2017
From
Poz
How a London clinic reduced new HIV infections by 90% and why more European cities can do the same

Scaling up HIV testing to reduce undiagnosed HIV infection requires a fundamental re-ordering of HIV testing services to make them more attractive to people at risk, and

Published
26 October 2017
By
Keith Alcorn
Health Group Challenges Gilead Patents In The US On Grounds Of Lack Of Novelty

A health advocacy group today announced that it has challenged a set of United States patents for a hepatitis C medicine. The group says drug maker Gilead Sciences has obtained unmerited patents for sofosbuvir, blocking millions of US patients from affordable treatment.

Published
26 October 2017
From
Intellectual Property Watch
HIV pills and new lung drugs keep GSK on track in third-quarter

GlaxoSmithKline (GSK.L) grew sales 4 percent in the third quarter, helped by demand for new products, keeping it on track to deliver on full-year financial targets as new Chief Executive Emma Walmsley refocuses the drugs pipeline.

Published
25 October 2017
From
Reuters
Price’s “Quarantine” Comment a Startling Example of Remaining HIV Stigma and Ignorance

What should we, as infectious diseases/HIV specialists, say about this regressive and anachronistic perspective? How about taking the high road and sticking to the science?

Published
25 October 2017
From
NEJM Journal Watch
New York City finds gaps in the HIV cascade of care linked to reduced survival

60% of HIV-positive people in New York City who died had not been virally suppressed through treatment. Rates of viral suppression lowest among women, young people, black and Hispanic people, as well as people in low-income neighbourhoods.

Published
25 October 2017
From
CATIE
Global Fund Names Finalist Candidates for Executive Director

The Global Fund Board named four finalist candidates for Executive Director, and is scheduled to select one at a Board meeting on 14 November 2017.

Published
24 October 2017
From
The Global Fund
The German CEO Pushing for an Immunotherapy to Treat Cancer and HIV

Mariola Söhngen, CEO of Mologen, discusses biotech entrepreneurship in Germany and her company’s unique immunotherapy against both cancer and HIV.

Published
23 October 2017
From
Labiotech.eu (blog)
LGBT charity criticised over staff guidelines allowing sex with clients

Yorkshire MESMAC says its policy on staff pursuing sexual relationships with service users was misconstrued but that it will be redrafted.

Published
23 October 2017
From
The Guardian

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.